{"id":26262,"date":"2026-09-21T07:43:19","date_gmt":"2026-09-21T07:43:19","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/"},"modified":"2026-09-21T10:37:46","modified_gmt":"2026-09-21T10:37:46","slug":"philip-morris-international-business-strategy-2026","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/","title":{"rendered":"Philip Morris International Business Strategy 2026"},"content":{"rendered":"

Philip Morris International\u2019s strategy in 2026 is not conventional diversification. It is deliberate self-disruption: use the scale, cash flow, brands and distribution of the cigarette business to build smoke-free categories designed eventually to make cigarettes economically secondary. In 2025, smoke-free products generated $16.9 billion and 41.5% of total net revenue despite representing only 22.3% of shipment volume. The strategy is therefore already changing the profit architecture of the company, not merely its product portfolio.<\/p>\n

PMI\u2019s 2030 ambition is for smoke-free products to exceed two-thirds of global net revenue. Achieving that requires continued consumer conversion, geographic expansion, category innovation and favorable regulatory access. The company\u2019s strategy can be understood through several mutually reinforcing moves.<\/p>\n

1. Accelerate the Revenue Mix Shift From Cigarettes to Smoke-Free Products<\/h2>\n

The core strategic KPI is no longer simply cigarette market share or total shipment volume. It is the proportion of company economics generated by smoke-free products. That share rose to 41.5% of net revenue in 2025, from 38.7% in 2024 and 36.4% in 2023. The steady progression shows that transformation is compounding rather than depending on one launch year.<\/p>\n

PMI\u2019s ambition of more than two-thirds by 2030 requires the smoke-free business to grow materially faster than combustibles for several more years. Importantly, management does not need cigarettes to collapse for the mix to shift. Strong smoke-free growth can mathematically reduce cigarette dependence even while combustible pricing preserves cash flow.<\/p>\n

This creates a more manageable transition. PMI can continue harvesting cash from established brands while reinvesting in the products intended to replace them. The strategic risk is incentive conflict: if cigarettes remain highly profitable, management must maintain discipline not to optimize the legacy business at the expense of long-term conversion.<\/p>\n

Related: Philip Morris International Business Model in 2026<\/a><\/em><\/p>\n

2. Build a Multicategory Portfolio Instead of Betting on One Technology<\/h2>\n

PMI\u2019s portfolio spans heated tobacco through IQOS, oral nicotine through ZYN and e-vapor through VEEV. The strategic logic is consumer heterogeneity. Not every smoker wants the same replacement experience, and regulatory frameworks vary widely across countries. A three-category architecture gives PMI more ways to meet preferences and more flexibility when one category faces restrictions.<\/p>\n

IQOS is the core international smoke-free driver because it leverages PMI\u2019s tobacco expertise and creates a device-plus-consumables ecosystem. ZYN adds a device-free oral format with strong U.S. momentum. VEEV provides an e-vapor offering and more than doubled international shipment volume in 2025. Together, the categories reduce technological concentration risk.<\/p>\n

The deeper advantage is cross-category learning. PMI can observe which consumers prefer which format, how price points influence switching and how retail execution changes adoption. That consumer intelligence can inform portfolio allocation in ways unavailable to a single-category competitor.<\/p>\n

3. Treat Consumer Conversion as a Five-Part Commercial System<\/h2>\n

PMI describes its approach through awareness, acceptability, availability, affordability and advocacy. This framework is strategically useful because smoke-free adoption is constrained by more than product quality. A smoker may fail to switch because they do not know the product exists, cannot access it, dislike it, cannot afford it or live in a regulatory system that limits availability.<\/p>\n

Awareness and acceptability require marketing and product innovation. Availability requires retail distribution and regulatory authorization. Affordability requires pricing architecture across income levels. Advocacy requires engagement with policymakers around differentiated regulation. The strategy succeeds only when all five work together.<\/p>\n

This is why PMI\u2019s historical cigarette capabilities still matter. Its retail relationships and local-market knowledge can be repurposed to accelerate smoke-free availability. The company is not building distribution from zero; it is transforming what its distribution system sells.<\/p>\n

Related: Philip Morris International SWOT Analysis in 2026<\/a><\/em><\/p>\n

4. Use IQOS as the International Conversion Platform<\/h2>\n

IQOS remains central because heated tobacco can preserve aspects of the tobacco experience while eliminating combustion. For adult smokers unwilling to move to oral nicotine or e-vapor, that similarity can reduce switching friction.<\/p>\n

The device ecosystem also deepens consumer relationships. Devices create opportunities for registration, service, digital engagement and upgrades, while consumables generate recurring revenue. This gives PMI more visibility into consumer behavior than traditional anonymous cigarette purchases through third-party retail.<\/p>\n

In 2025, the Europe region became majority smoke-free by net revenue in the fourth quarter, joining other regional segments that had already crossed that threshold. The significance is not symbolic: it demonstrates that a large legacy cigarette geography can become economically majority smoke-free while PMI remains profitable.<\/p>\n

5. Make ZYN a Second Global Growth Engine<\/h2>\n

The Swedish Match acquisition gave PMI leadership in modern oral nicotine and transformed its U.S. position. U.S. ZYN shipments grew 37% in 2025, making the brand one of PMI\u2019s fastest-growing assets.<\/p>\n

ZYN is strategically complementary to IQOS. It requires no electronic device, no heating and no inhalation, making usage occasions and consumer preferences different. That means PMI can participate in nicotine demand beyond the contexts historically served by smoking.<\/p>\n

The company is investing in U.S. manufacturing capacity, which converts demand growth into a supply-chain challenge. Capacity investment is strategically important because shortages can slow consumer acquisition and allow competitors to gain shelf space. Manufacturing therefore becomes a growth enabler rather than a back-end function.<\/p>\n

6. Expand Smoke-Free Availability Geographically<\/h2>\n

Smoke-free products were available in 106 markets at the end of 2025, and approximately 43.5 million adults used them. Geographic expansion increases the addressable population, but the more interesting metric is depth: 27 markets already generated more than half of net revenue from smoke-free products.<\/p>\n

In markets where smoke-free products had been available for at least three years, the category represented 49.5% of annual net revenue. That suggests adoption has a maturation curve. Initial market entry builds awareness and distribution; subsequent years deepen penetration. PMI\u2019s future growth can therefore come from both entering new markets and compounding within existing ones.<\/p>\n

This creates a portfolio of adoption curves. Mature smoke-free markets demonstrate the endpoint, newer markets provide growth, and markets awaiting authorization represent future options. Geographic sequencing can smooth growth across years.<\/p>\n

Related: Philip Morris International PESTEL Analysis in 2026<\/a><\/em><\/p>\n

7. Preserve Combustible Economics While Funding Their Replacement<\/h2>\n

PMI said combustibles delivered robust top- and bottom-line performance in 2025 through pricing, portfolio resilience and execution. Strategically, this matters because transformation requires capital. Weakening the legacy business too quickly could reduce the cash available for smoke-free R&D, capacity and commercialization.<\/p>\n

The company must therefore manage cigarettes for cash without making cigarette growth the long-term objective. Pricing can offset declining volumes and preserve margins, but there are limits: higher prices can increase illicit trade, affordability problems and regulatory pressure.<\/p>\n

This is a classic innovator\u2019s dilemma with an unusual twist. PMI is explicitly choosing to disrupt its historically dominant product. The quality of management execution will be measured by whether smoke-free growth becomes large enough before combustible economics structurally deteriorate.<\/p>\n

8. Use Science and Regulation as Competitive Capabilities<\/h2>\n

PMI has invested more than $16 billion since 2008 in developing, scientifically substantiating and commercializing smoke-free products. Scientific substantiation is economically important because nicotine categories are heavily regulated and regulators may require evidence before products can be marketed or before risk-related claims can be made.<\/p>\n

FDA authorizations for ZYN, IQOS and General snus demonstrate that regulatory science can become a barrier to entry. A competitor needs more than a consumer product; it may need extensive toxicology, clinical and behavioral evidence. PMI\u2019s scientific infrastructure therefore supports both legitimacy and market access.<\/p>\n

The strategic tension is that regulatory outcomes remain outside management\u2019s full control. A strong product can still face delays or restrictions. Geographic and category diversification partially mitigates this by ensuring PMI is not dependent on one regulator.<\/p>\n

9. Reorganize the Company Around the Future Business<\/h2>\n

Effective January 2026, PMI replaced four geographic reporting segments with International Smoke-Free, International Combustibles and U.S. segments. This is more than accounting presentation. Organizational structure shapes accountability, resource allocation and management attention.<\/p>\n

Separating International Smoke-Free from International Combustibles makes the economics of transformation more visible. Management can evaluate growth, margins and investment by business model rather than allowing smoke-free performance to disappear inside geographic aggregates.<\/p>\n

The U.S. segment recognizes that the market has become strategically distinct because of ZYN, IQOS opportunities, FDA regulation and domestic manufacturing investment. PMI is therefore redesigning the organization around where future value is expected to come from.<\/p>\n

10. Extend Capabilities Beyond Tobacco and Nicotine Over Time<\/h2>\n

PMI has a long-term ambition to expand into wellness and healthcare. This is not yet the primary earnings engine, and the company\u2019s 2025 results remain overwhelmingly driven by nicotine. But the direction matters because smoke-free transformation has forced PMI to build capabilities in life sciences, inhalation, consumer health, devices and regulatory science.<\/p>\n

The strategic question is whether those capabilities can create credible adjacencies. Diversification only creates value if PMI possesses transferable advantages. Scientific assessment, regulated-product manufacturing and consumer behavior expertise may transfer better than cigarette branding alone.<\/p>\n

Management should therefore be selective. The strongest adjacencies will be those where existing technology, regulatory or commercial infrastructure reduces the cost of entry rather than simply offering a large market.<\/p>\n

Strategic Synthesis: PMI\u2019s Self-Disruption Flywheel<\/h2>\n

PMI\u2019s strategy works as a flywheel. Combustibles generate cash and distribution reach. That cash funds smoke-free science, manufacturing and market entry. Smoke-free products acquire consumers and create higher-value revenue pools. Scale improves manufacturing economics and supports further innovation. As smoke-free revenue grows, dependence on cigarettes falls.<\/p>\n

The 2025 numbers suggest the flywheel is becoming economically self-sustaining. Smoke-free products generated 41.5% of revenue and 43% of adjusted gross profit contribution. Adjusted operating margin exceeded 40%, and adjusted EPS grew 15%. The company is therefore demonstrating that transformation can coexist with improving profitability.<\/p>\n

The next phase is harder because moving from 41.5% to more than two-thirds of revenue requires smoke-free products to become the dominant business globally. That demands deeper penetration in existing markets, new regulatory authorizations, sufficient manufacturing capacity and continued consumer acceptance across IQOS, ZYN and VEEV.<\/p>\n

PMI\u2019s strategy in 2026 is consequently not about finding a new growth product. It is about replacing the economic center of gravity of the company while preserving the cash flow needed to finance that replacement. Few large consumer companies attempt transformation at this scale. PMI\u2019s competitive advantage is that the new business already has tens of millions of users and nearly $17 billion of revenue; its risk is that regulation, consumer behavior and legacy-business economics must remain aligned long enough to complete the transition.<\/p>\n

11. Make Profitability a Constraint on Transformation, Not a Casualty of It<\/h2>\n

PMI\u2019s 2025 adjusted operating margin returned above 40%, while adjusted diluted EPS grew 15% in dollar terms. These results impose an important discipline on strategy: management is not asking shareholders to accept indefinite margin compression in exchange for a distant smoke-free future. The transformation is expected to create growth and profitability simultaneously.<\/p>\n

This changes how capital should be allocated among categories. Investment cannot be justified only by shipment growth. IQOS, ZYN and VEEV must ultimately produce attractive consumer lifetime value after device subsidies, marketing, regulatory science and manufacturing investment. A category that grows quickly but requires permanently uneconomic acquisition spending would not strengthen the transformation.<\/p>\n

Margin discipline also helps distinguish scale from quality. Smoke-free products already contribute 43% of adjusted gross profit, slightly above their share of net revenue. As the portfolio scales, management should be able to reinvest part of that profit into innovation while allowing operating leverage to reach shareholders.<\/p>\n

The strategic advantage is credibility. A transformation that improves earnings while changing the portfolio is easier to finance and sustain than one dependent on investor patience. Strong current economics give PMI time to navigate regulatory delays and uneven adoption across markets without abandoning the long-term objective.<\/p>\n

Source:<\/strong> Philip Morris International, 2025 Annual Report<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.<\/p>\n","protected":false},"author":3,"featured_media":26298,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[164],"tags":[],"class_list":{"0":"post-26262","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business-intelligence"},"yoast_head":"\nPhilip Morris International Business Strategy 2026 - The Strategy Story<\/title>\n<meta name=\"description\" content=\"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Philip Morris International Business Strategy 2026 - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-21T07:43:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-21T10:37:46+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/09\/afif-ramdhasuma-EM5rSFcLUdA-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Shikhar Goel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shikhar Goel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/\",\"name\":\"Philip Morris International Business Strategy 2026 - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-09-21T07:43:19+00:00\",\"dateModified\":\"2026-09-21T10:37:46+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\"},\"description\":\"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.\",\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Philip Morris International Business Strategy 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\",\"name\":\"Shikhar Goel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"caption\":\"Shikhar Goel\"},\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Philip Morris International Business Strategy 2026 - The Strategy Story","description":"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/","og_locale":"en_US","og_type":"article","og_title":"Philip Morris International Business Strategy 2026 - The Strategy Story","og_description":"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.","og_url":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/","og_site_name":"The Strategy Story","article_published_time":"2026-09-21T07:43:19+00:00","article_modified_time":"2026-09-21T10:37:46+00:00","og_image":[{"width":640,"height":427,"url":"http:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/09\/afif-ramdhasuma-EM5rSFcLUdA-unsplash.jpg","type":"image\/jpeg"}],"author":"Shikhar Goel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shikhar Goel","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/","url":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/","name":"Philip Morris International Business Strategy 2026 - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-09-21T07:43:19+00:00","dateModified":"2026-09-21T10:37:46+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071"},"description":"Philip Morris International business strategy 2026: IQOS, ZYN, VEEV, smoke-free growth, global scale and the transition away from cigarettes.","breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/philip-morris-international-business-strategy-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Philip Morris International Business Strategy 2026"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071","name":"Shikhar Goel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","caption":"Shikhar Goel"},"url":"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/26262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=26262"}],"version-history":[{"count":3,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/26262\/revisions"}],"predecessor-version":[{"id":26339,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/26262\/revisions\/26339"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media\/26298"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=26262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=26262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=26262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}